Procter & Gamble Hygiene and Health Care Limited announced its unaudited financial results for the quarter ended September 30, 2025. The company reported a total income of ₹1160.07 million and a profit after tax of ₹209.86 million. Earnings per share stood at ₹64.65 (basic and diluted). The results were approved by the Board of Directors on November 6, 2025.
Financial Performance Overview
Procter & Gamble Hygiene and Health Care Limited (P&G) has released its unaudited financial results for the second quarter (Q2) of fiscal year 2026, ending September 30, 2025. Here’s a summary of their performance:
Key Financial Highlights
- Total Income: ₹1160.07 million compared to ₹944.72 million in the preceding quarter and ₹1143.66 million in the corresponding quarter of the previous year.
- Profit Before Tax: ₹281.78 million for the quarter.
- Profit After Tax: ₹209.86 million, compared to ₹192.06 million in the previous quarter and ₹211.90 million in the corresponding quarter last year.
- Earnings Per Share: Basic and diluted EPS both stand at ₹64.65.
Six-Month Performance
The cumulative results for the six months ended September 30, 2025, are as follows:
- Total Income: ₹2104.79 million.
- Profit Before Tax: ₹546.48 million.
- Profit After Tax: ₹401.92 million.
Statement of Assets and Liabilities Highlights
Key figures from the statement of assets and liabilities as of September 30, 2025:
- Total Assets: ₹2133.41 million.
- Total Equity: ₹931.27 million.
Board Approval
The results were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on November 6, 2025.
Source: BSE
